BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10601533)

  • 1. Increased resting energy expenditure is related to plasma TNF-alpha concentration in stable COPD patients.
    Nguyen LT; Bedu M; Caillaud D; Beaufrère B; Beaujon G; Vasson M; Coudert J; Ritz P
    Clin Nutr; 1999 Oct; 18(5):269-74. PubMed ID: 10601533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
    Schols AM; Buurman WA; Staal van den Brekel AJ; Dentener MA; Wouters EF
    Thorax; 1996 Aug; 51(8):819-24. PubMed ID: 8795671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L; de Muralt B; Schutz Y; Fitting JW
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty.
    Sridhar MK; Carter R; Lean ME; Banham SW
    Thorax; 1994 Aug; 49(8):781-5. PubMed ID: 8091323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.
    Baarends EM; Schols AM; Westerterp KR; Wouters EF
    Thorax; 1997 Sep; 52(9):780-5. PubMed ID: 9371208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting energy expenditure in patients with chronic obstructive pulmonary disease.
    Schols AM; Fredrix EW; Soeters PB; Westerterp KR; Wouters EF
    Am J Clin Nutr; 1991 Dec; 54(6):983-7. PubMed ID: 1957831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis.
    Burdet L; Hugli O; Aubert JD; Schutz Y; Roulet M; Fitting JW
    Eur J Pediatr; 1999 Sep; 158(9):711-6. PubMed ID: 10485301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer.
    Wu J; Huang C; Xiao H; Tang Q; Cai W
    Nutrition; 2013; 29(11-12):1310-4. PubMed ID: 24012284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic rate and weight loss in chronic obstructive lung disease.
    Wilson DO; Donahoe M; Rogers RM; Pennock BE
    JPEN J Parenter Enteral Nutr; 1990; 14(1):7-11. PubMed ID: 2325244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of theophylline on metabolic rate in chronic obstructive lung disease patients.
    Mosier K; Renvall MJ; Ramsdell JW; Spindler AA
    J Am Coll Nutr; 1996 Aug; 15(4):403-7. PubMed ID: 8829097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cachexia and related components on pulmonary functions in patients with COPD.
    Görek Dilektaşli A; Ulubay G; Bayraktar N; Eminsoy I; Oner Eyüboğlu F
    Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of TNF-alpha and leptin on weight loss in patients with stable chronic obstructive pulmonary disease.
    Shin KC; Chung JH; Lee KH
    Korean J Intern Med; 2007 Dec; 22(4):249-55. PubMed ID: 18309683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease.
    Sergi G; Coin A; Marin S; Vianello A; Manzan A; Peruzza S; Inelmen EM; Busetto L; Mulone S; Enzi G
    Respir Med; 2006 Nov; 100(11):1918-24. PubMed ID: 16635565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.
    Falconer JS; Fearon KC; Plester CE; Ross JA; Carter DC
    Ann Surg; 1994 Apr; 219(4):325-31. PubMed ID: 7512810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease.
    Baarends EM; Schols AM; Pannemans DL; Westerterp KR; Wouters EF
    Am J Respir Crit Care Med; 1997 Feb; 155(2):549-54. PubMed ID: 9032193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equations for the prediction of resting energy expenditure in chronic obstructive lung disease.
    Moore JA; Angelillo VA
    Chest; 1988 Dec; 94(6):1260-3. PubMed ID: 3191768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of energy prediction equations with measured resting energy expenditure in children with sickle cell anemia.
    Williams R; Olivi S; Mackert P; Fletcher L; Tian GL; Wang W
    J Am Diet Assoc; 2002 Jul; 102(7):956-61. PubMed ID: 12146559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic activities of theophylline in chronic obstructive pulmonary disease.
    Peleman RA; Kips JC; Pauwels RA
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():53-6. PubMed ID: 9756187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
    Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
    Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
    Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
    Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.